We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,306.00
Bid: 2,306.00
Ask: 2,308.00
Change: -33.00 (-1.41%)
Spread: 2.00 (0.09%)
Open: 2,325.00
High: 2,393.00
Low: 2,306.00
Yest. Close: 2,339.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

TOP NEWS: Hikma Reiterates Guidance For 2016 On Good Start

12 May 16 06:49

AGM, EGM Calendar - Week Ahead

5 May 16 15:13

Director dealings: Hikma gets shot in the arm as chief tops up

(ShareCast News) - Hikma Pharmaceuticals's chief Said Darwazah boosted his stake in the generic drugs firm on Wednesday to 5.49% through the acquisition of 30,000 shares at an individual price of 2,271p. The transaction was carried out by Vidacos Nominees on behalf of Darhold Limited, in which Darwa

20 Apr 16 16:38

Director dealing: Hikma directors keep buying

(ShareCast News) - Hikma Pharmaceuticals' newest board member has bought himself some skin in the game, following his chief executive's lead. US public affairs veteran John Castellani, who was appointed to the board in February, spent around £53,000 buying 2,500 shares at a price of 2,103p apiece.

12 Apr 16 15:32

DIRECTOR DEALINGS: Hikma Non-Executive Director Buys First Shares

12 Apr 16 09:48

LONDON MARKET CLOSE: Oil Rally Helps FTSE 100 To Highest 2016 Close

8 Apr 16 15:55

LONDON MARKET MIDDAY: "Risky" Oil Price Rally Supports Stocks

8 Apr 16 11:10

WINNERS & LOSERS SUMMARY: Pathfinder Sinks After Mozambique Ruling

8 Apr 16 09:56

Hikma filing for generic of Glaxo's Advair Diskus accepted by US FDA

(ShareCast News) - Hikma Pharmaceuticals said on Friday that its abbreviated new drug application for fluticasone propionate and salmeterol inhalation powder has been accepted for filing by the Food and Drug Administration in the US. The product is the generic version of GlaxoSmithKline's Advair Dis

8 Apr 16 08:20

LONDON MARKET OPEN: Resource Stocks Lead Gainers As Oil Recovers

8 Apr 16 07:37

US Accepts Hikma, Vectura Filing For Generic Of Glaxo's Advair Diskus

8 Apr 16 06:48

London-listed pharmas rally as Pfizer-Allergan deal collapses

(ShareCast News) - Shares in pharmaceuticals companies Shire, AstraZeneca and GlaxoSmithKline rallied on Wednesday as investors bet that the termination of Pfizer's agreement to buy Allergan might make the London-listed companies bid targets. US drug maker Pfizer said on Wednesday that its $160bn ag

6 Apr 16 10:20

Director dealings: Hikma boss buys £600K worth of shares

(ShareCast News) - The chairman and chief executive of Hikma Pharmaceuticals has purchased more than £600,000 worth of shares in the drugmaker. Said Darwazah bought 30,000 shares for 2,055.00p each, totalling £616,499.98 JP Morgan on Wednesday reiterated its 'overweight' rating on the stock and set

5 Apr 16 17:15

DIRECTOR DEALINGS: Hikma Chief Darwazah Builds Stake Through Darhold

31 Mar 16 16:55

Dividends Calendar - Week Ahead

31 Mar 16 15:15

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.